Page 20 - Miauw 2020 - 04

Feline hypertrofische cardiomyopathie (FHCM)

Valerie Bavegem legt uit

ReferenDes:

Borgeat, K. et al. (2015). The influence of clinical and geneDc factors on leC

ventricular wall thickness in Ragdoll cats. Journal of Veterinary Cardiology
17 (Suppl. 1), 258-267.

Coté, E. et al. (2011). Hypertrophic cardiomyopathy. In: Côté, E., MacDonald,

K.A., Meurs, K.M., Sleeper, M.M. (editors). Feline Cardiology. John Wiley &
Sons, Chichester, UK, Chapter 11, pp. 103-175,

Fox, P.R. et al. (2018). InternaDonal collaboraDve study to assess cardiovascu-

lar risk and evaluate long-term health in cats with preclini-cal hypertro-
phic cardiomyopathy and apparently healthy cats: the REVEAL study. Jour-

nal of Veterinary Internal Medicine 32, 930-943.

Fuentes, V.L. et al. (2020). ACVIM consensus statement guidelines for the
classificaDon, diagnosis, and management of cardiomyopathies in cats.

Journal of Veterinary Internal Medicine 34, 1062–1077

Häggström, J. et al. (2015). Screen-ing for hypertrophic cardiomyopathy in
cats. Journal of Veterinary Cardiology 17 (Suppl. 1), 134-149.

Häggström, J. et al. (2016). Effect of body weight on echocardiographic mea-
surements in 19.866 pure-bred cats with or without heart disease. Journal

of Veterinary Internal Medicine 30, 1601-1611.

Maron, B.J. and Fox, P.R. (2015). Hypertrophic cardiomyopa-thy in man and
cats. Journal of Veterinary Cardiology 17 (Suppl. 1), 6-9

Payne, J.R. et al. (2015). Car-diomyopathy prevalence in 780 apparently

healthy cats in rehoming centres (the CatScan study). Journal of Veterina-
ry Cardiology 17 (Suppl. 1), 244-257.

Schipper, T. et al. (2020). An overview of the current geneDc and phenotypi-

cal selecDon strategies to reduce the prevalence of feline hypertrophic
cardiomyopathy. Vlaams Diergeneeskundig Tijdschri# 89, 69-80.

20